BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35140782)

  • 1. Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis.
    Pakoz ZB; Ustaoglu M; Vatansever S; Yuksel ES; Topal F
    Gastroenterol Res Pract; 2022; 2022():9987214. PubMed ID: 35140782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index as a potential biomarker to monitor ulcerative colitis.
    Yan J; Deng F; Tan Y; Zhou B; Liu D
    Curr Med Res Opin; 2023 Oct; 39(10):1321-1328. PubMed ID: 37691449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients.
    Xie Y; Zhuang T; Ping Y; Zhang Y; Wang X; Yu P; Duan X
    Clin Chim Acta; 2021 Jun; 517():122-126. PubMed ID: 33662359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective immune-inflammation index for ulcerative colitis and activity assessments.
    Zhang MH; Wang H; Wang HG; Wen X; Yang XZ
    World J Clin Cases; 2021 Jan; 9(2):334-343. PubMed ID: 33521101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
    Shin J; Kong SM; Seong G; Kim YH
    Int J Colorectal Dis; 2020 Dec; 35(12):2249-2255. PubMed ID: 32749515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pan-immune inflammatory value and ulcerative colitis.
    Mete Yıldırım A; Yıldırım O
    Curr Med Res Opin; 2024 Apr; 40(4):599-603. PubMed ID: 38343292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis.
    Yamazato M; Yanai S; Oizumi T; Eizuka M; Yamada S; Toya Y; Uesugi N; Sugai T; Matsumoto T
    World J Clin Cases; 2023 Nov; 11(32):7753-7760. PubMed ID: 38073694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio.
    Sayar S; Kurbuz K; Kahraman R; Caliskan Z; Atalay R; Ozturk O; Doganay HL; Ozdil K
    North Clin Istanb; 2020; 7(1):49-55. PubMed ID: 32232203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis.
    Zhang XF; Li P; Ding XL; Chen H; Wang SJ; Jin SB; Guo J; Tian ZB
    Gastroenterol Rep (Oxf); 2021 Dec; 9(6):533-542. PubMed ID: 34925850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type.
    Sonoyama H; Kawashima K; Ishihara S; Kotani S; Fukuba N; Oka A; Kusunoki R; Tada Y; Mishima Y; Oshima N; Moriyama I; Yuki T; Onishi K; Kinoshita Y
    J Clin Biochem Nutr; 2019 May; 64(3):265-270. PubMed ID: 31138962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis.
    Arai Y; Arihiro S; Matsuura T; Kato T; Matsuoka M; Saruta M; Mitsunaga M; Matsuura M; Fujiwara M; Okayasu I; Ito S; Tajiri H
    Inflamm Bowel Dis; 2014 Jul; 20(7):1208-16. PubMed ID: 24846719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Lawlor GO; Zenlea T; Goldsmith JD; Gifford A; Falchuk KR; Wolf JL; Cheifetz AS; Robson SC; Moss AC
    Inflamm Bowel Dis; 2013; 19(4):779-84. PubMed ID: 23446338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis.
    Motooka K; Morishita K; Ito N; Shinzaki S; Tashiro T; Nojima S; Shimizu K; Date M; Sakata N; Yamada M; Takamatsu S; Kamada Y; Iijima H; Mizushima T; Morii E; Takehara T; Miyoshi E
    World J Gastroenterol; 2021 Jan; 27(2):162-175. PubMed ID: 33510557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis.
    Wu J; Yan L; Chai K
    J Clin Lab Anal; 2021 Sep; 35(9):e23964. PubMed ID: 34418163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis.
    Maeda K; Nakamura M; Yamamura T; Sawada T; Ishikawa E; Oishi A; Ikegami S; Kakushima N; Furukawa K; Iida T; Mizutani Y; Ishikawa T; Ohno E; Honda T; Ishigami M; Kawashima H
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.